139 related articles for article (PubMed ID: 17008536)
1. Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia.
Lehrnbecher T; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Creutzig U
Blood; 2007 Feb; 109(3):936-43. PubMed ID: 17008536
[TBL] [Abstract][Full Text] [Related]
2. Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies.
Kang KW; Kim DS; Lee SR; Sung HJ; Kim SJ; Choi CW; Kim BS; Park Y
Leuk Res; 2017 Jun; 57():1-8. PubMed ID: 28231491
[TBL] [Abstract][Full Text] [Related]
3. Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group.
Alonzo TA; Kobrinsky NL; Aledo A; Lange BJ; Buxton AB; Woods WG
J Pediatr Hematol Oncol; 2002 Nov; 24(8):627-35. PubMed ID: 12439034
[TBL] [Abstract][Full Text] [Related]
4. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of 2 dosages of prophylactic granulocyte-colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia.
Inaba H; Cao X; Pounds S; Pui CH; Rubnitz JE; Ribeiro RC; Razzouk BI
Cancer; 2011 Mar; 117(6):1313-20. PubMed ID: 21381017
[TBL] [Abstract][Full Text] [Related]
6. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study.
Usuki K; Urabe A; Masaoka T; Ohno R; Mizoguchi H; Hamajima N; Miyazaki T; Niitsu Y; Yoshida Y; Miura A; Shibata A; Abe T; Miura Y; Ikeda Y; Nomura T; Nagao T; Saitou H; Shirakawa S; Ohkuma M; Matsuda T; Nakamura T; Horiuchi A; Kuramoto A; Kimura I; Irino S; Niho Y; Takatsuki K; Tomonaga M; Uchino H; Takaku F;
Br J Haematol; 2002 Jan; 116(1):103-12. PubMed ID: 11841402
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
[TBL] [Abstract][Full Text] [Related]
9. Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multicenter randomized controlled study in southwest China.
Gao L; Wen Q; Chen X; Liu Y; Zhang C; Gao L; Kong P; Zhang Y; Li Y; Liu J; Wang Q; Su Y; Wang C; Wang S; Zeng Y; Sun A; Du X; Zeng D; Liu H; Peng X; Zhang X
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1932-9. PubMed ID: 25109850
[TBL] [Abstract][Full Text] [Related]
10. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
Feng X; Lan H; Ruan Y; Li C
Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.
Maslak PG; Weiss MA; Berman E; Yao TJ; Tyson D; Golde DW; Scheinberg DA
Leukemia; 1996 Jan; 10(1):32-9. PubMed ID: 8558934
[TBL] [Abstract][Full Text] [Related]
12. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
[TBL] [Abstract][Full Text] [Related]
13. Role of granulocyte colony-stimulating factor as adjunct therapy for septicemia in children with acute leukemia.
Liang DC; Chen SH; Lean SF
Am J Hematol; 1995 Feb; 48(2):76-81. PubMed ID: 7531394
[TBL] [Abstract][Full Text] [Related]
14. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
[TBL] [Abstract][Full Text] [Related]
15. Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length.
Li AM; Thyagu S; Maze D; Schreiber R; Sirrs S; Stockler-Ipsiroglu S; Sutherland H; Vercauteren S; Schultz KR
Pediatr Hematol Oncol; 2018 Feb; 35(1):45-51. PubMed ID: 29652549
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse.
Ehlers S; Herbst C; Zimmermann M; Scharn N; Germeshausen M; von Neuhoff N; Zwaan CM; Reinhardt K; Hollink IH; Klusmann JH; Lehrnbecher T; Roettgers S; Stary J; Dworzak M; Welte K; Creutzig U; Reinhardt D
J Clin Oncol; 2010 May; 28(15):2591-7. PubMed ID: 20406937
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
Stone RM; Berg DT; George SL; Dodge RK; Paciucci PA; Schulman P; Lee EJ; Moore JO; Powell BL; Schiffer CA
N Engl J Med; 1995 Jun; 332(25):1671-7. PubMed ID: 7760868
[TBL] [Abstract][Full Text] [Related]
18. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
Bradley AM; Deal AM; Buie LW; van Deventer H
Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
[TBL] [Abstract][Full Text] [Related]
19. Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical trial.
Bennett CL; Hynes D; Godwin J; Stinson TJ; Golub RM; Appelbaum FR;
Cancer Invest; 2001; 19(6):603-10. PubMed ID: 11486703
[TBL] [Abstract][Full Text] [Related]
20. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.
Löwenberg B; van Putten W; Theobald M; Gmür J; Verdonck L; Sonneveld P; Fey M; Schouten H; de Greef G; Ferrant A; Kovacsovics T; Gratwohl A; Daenen S; Huijgens P; Boogaerts M; ;
N Engl J Med; 2003 Aug; 349(8):743-52. PubMed ID: 12930926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]